Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.91)
# 254
Out of 5,081 analysts
1154
Total ratings
46.7%
Success rate
26.9%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAM Beam Therapeutics | Reiterated: Buy | $80 | $23.79 | +236.28% | 32 | Oct 27, 2026 | |
| FTH Faeth Therapeutics | Reiterated: Buy | $60 | $16.83 | +256.51% | 6 | Oct 27, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterated: Buy | $55 | $36.83 | +49.33% | 30 | Oct 27, 2026 | |
| IMCR Immunocore Holdings | Reiterated: Buy | $100 | $31.28 | +219.69% | 55 | Oct 26, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $195 | $83.27 | +134.18% | 1 | Oct 22, 2026 | |
| SLN Silence Therapeutics | Downgraded: Hold | $75 → $20 | $19.78 | +1.11% | 45 | Oct 21, 2026 | |
| AGMB AgomAb Therapeutics NV | Reiterated: Buy | $35 | $8.57 | +308.40% | 7 | Oct 20, 2026 | |
| ANRO Alto Neuroscience | Reiterated: Buy | $55 → $60 | $22.11 | +171.37% | 23 | Oct 19, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $120 | $58.98 | +103.46% | 75 | Oct 15, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $22 | $11.04 | +99.28% | 70 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $4.65 | +975.27% | 23 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.05 | +875.61% | 51 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $19.67 | +154.19% | 18 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $31.54 | +90.23% | 13 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.5892 | +1,597.22% | 42 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $21.65 | +269.52% | 63 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $455 | $227.66 | +99.86% | 79 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $11.05 | +488.24% | 62 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $51.09 | +183.81% | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $6.41 | +836.04% | 68 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $90 | $9.15 | +883.61% | 52 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9064 | +1,003.27% | 9 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $2.55 | +1,664.71% | 14 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.4732 | +956.64% | 52 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.75 | +1,328.57% | 30 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $35.68 | +96.19% | 46 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $19.18 | +238.89% | 40 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1161 | - | 51 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $10 | $0.6444 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $360 | $8.45 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.59 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.055 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | 4p | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €33.00 | €2.80 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $40.77 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $130 | $12.00 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $15.82 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $21.05 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $3.50 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $109.63 | n/a | 1 | Dec 23, 2014 |
Beam Therapeutics
Oct 27, 2026
Reiterated: Buy
Price Target: $80
Current: $23.79
Upside: +236.28%
Faeth Therapeutics
Oct 27, 2026
Reiterated: Buy
Price Target: $60
Current: $16.83
Upside: +256.51%
Harmony Biosciences Holdings
Oct 27, 2026
Reiterated: Buy
Price Target: $55
Current: $36.83
Upside: +49.33%
Immunocore Holdings
Oct 26, 2026
Reiterated: Buy
Price Target: $100
Current: $31.28
Upside: +219.69%
Mirum Pharmaceuticals
Oct 22, 2026
Reiterated: Buy
Price Target: $195
Current: $83.27
Upside: +134.18%
Silence Therapeutics
Oct 21, 2026
Downgraded: Hold
Price Target: $75 → $20
Current: $19.78
Upside: +1.11%
AgomAb Therapeutics NV
Oct 20, 2026
Reiterated: Buy
Price Target: $35
Current: $8.57
Upside: +308.40%
Alto Neuroscience
Oct 19, 2026
Reiterated: Buy
Price Target: $55 → $60
Current: $22.11
Upside: +171.37%
Arrowhead Pharmaceuticals
Oct 15, 2026
Reiterated: Buy
Price Target: $120
Current: $58.98
Upside: +103.46%
Vir Biotechnology
Oct 15, 2026
Reiterated: Buy
Price Target: $22
Current: $11.04
Upside: +99.28%
Oct 8, 2026
Reiterated: Buy
Price Target: $50
Current: $4.65
Upside: +975.27%
Oct 8, 2026
Reiterated: Buy
Price Target: $20
Current: $2.05
Upside: +875.61%
Oct 8, 2026
Reiterated: Buy
Price Target: $50
Current: $19.67
Upside: +154.19%
Oct 6, 2026
Reiterated: Buy
Price Target: $60
Current: $31.54
Upside: +90.23%
Sep 30, 2026
Reiterated: Buy
Price Target: $10
Current: $0.5892
Upside: +1,597.22%
Sep 30, 2026
Reiterated: Buy
Price Target: $80
Current: $21.65
Upside: +269.52%
Sep 21, 2026
Reiterated: Buy
Price Target: $455
Current: $227.66
Upside: +99.86%
Sep 21, 2026
Reiterated: Buy
Price Target: $65
Current: $11.05
Upside: +488.24%
Sep 21, 2026
Reiterated: Buy
Price Target: $145
Current: $51.09
Upside: +183.81%
Sep 21, 2026
Reiterated: Buy
Price Target: $60
Current: $6.41
Upside: +836.04%
Sep 21, 2026
Reiterated: Buy
Price Target: $160 → $90
Current: $9.15
Upside: +883.61%
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $0.9064
Upside: +1,003.27%
Sep 21, 2026
Reiterated: Buy
Price Target: $45
Current: $2.55
Upside: +1,664.71%
Sep 21, 2026
Reiterated: Buy
Price Target: $5
Current: $0.4732
Upside: +956.64%
Sep 21, 2026
Reiterated: Buy
Price Target: $25
Current: $1.75
Upside: +1,328.57%
Sep 15, 2026
Reiterated: Buy
Price Target: $70
Current: $35.68
Upside: +96.19%
Aug 10, 2026
Reiterated: Buy
Price Target: $65
Current: $19.18
Upside: +238.89%
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.1161
Upside: -
Apr 2, 2025
Reiterated: Buy
Price Target: $25 → $10
Current: $0.6444
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $20 → $360
Current: $8.45
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $8.59
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.055
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: 4p
Upside: n/a
Mar 27, 2020
Reiterated: Buy
Price Target: €33.00
Current: €2.80
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $40.77
Upside: n/a
Sep 18, 2019
Reiterated: Buy
Price Target: $120 → $130
Current: $12.00
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $15.82
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $21.05
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $3.50
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $109.63
Upside: n/a